Skip to main content
An official website of the United States government

Office of HIV and AIDS Malignancy

The NCI has played a major role in HIV/AIDS research since the beginning of the epidemic, when a cluster of cases of Kaposi's sarcoma was one of the harbingers of this new disease. NCI scientists have made a number of key discoveries in both HIV/AIDS and AIDS-associated cancer. Today, this research is coordinated by the Office of HIV and AIDS Malignancy (OHAM) and carried out in multiple divisions and offices of the NCI.

For patient information about HIV-associated malignancies, see Infectious Agents and HIV Infection and Cancer Risk.

  • NCI HIV and AIDS Research

    OHAM coordinates and oversees HIV and AIDS malignancy research programs throughout the NCI. Learn how NCI's major programs and initiatives are driving advances towards more effective prevention, diagnosis, and treatment of HIV/AIDS and HIV-associated malignancies.

  • NCI Funding for HIV and AIDS Malignancies Research

    Find funding for research to advance the study of HIV/AIDS-related cancers, including the application of big data and multidisciplinary studies that investigate treatment, co-infection, and aids-defining or non-aids-defining cancers.

  • HIV and AIDS Research Resources

    NCI makes a number of resources available to investigators researching HIV/AIDS and HIV-malignancies. Find information on resources provided by the NCI that are specific to research in HIV/AIDS and HIV-associated malignancies and links to selected resources provided by other components of the NIH.

  • HIV and AIDS Research News & Events

    OHAM monitors developments in HIV/AIDS research and curates a list of relevant events. Keep up-to-date with news about HIV/AIDS-related cancer research and learn about meetings and conferences in the field.

  • About the Office of HIV and AIDS Malignancy

    The Office of HIV and AIDS Malignancy enhances NCI’s research in the field of HIV/AIDS and facilitates the NCI-wide coordination of this effort. Learn more about the clinical and programmatic initiatives that OHAM oversees.